Electra Therapeutics, Inc. (ETRA) Insider Trading

Electra Therapeutics, Inc. (ETRA)

Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.

Showing latest transactions and SEC Form 4 filings for ETRA.

32 results.

X Filing Date Trade Date Ticker Company Name Insider Name Title Trade Type Price Qty Owned ΔOwn Value
M 2026-11-10 20:14:08 2026-11-10 ETRA Electra Therapeutics, Inc. GORDON CARL L Director, 10% Owner P - Purchase $8.08 +92,116 22,284,171 +0% +$744,531
M 2026-11-10 20:09:58 2026-11-10 ETRA Electra Therapeutics, Inc. ORBIMED ADVISORS LLC Director, 10% Owner P - Purchase $8.08 +92,116 22,284,171 +0% +$744,531
M 2026-11-05 17:47:52 2026-11-05 ETRA Electra Therapeutics, Inc. GORDON CARL L Director, 10% Owner P - Purchase $7.63 +472,571 35,873,607 +0% +$3,605,116
M 2026-11-05 17:39:46 2026-11-05 ETRA Electra Therapeutics, Inc. ORBIMED ADVISORS LLC Director, 10% Owner P - Purchase $7.63 +472,571 35,873,607 +0% +$3,605,116